← Back to headlines
Jasper Therapeutics Beats Q2 Earnings but Shares Decline
Jasper Therapeutics exceeded its second-quarter earnings expectations, with GAAP EPS beating forecasts. Despite the positive earnings, the company's stock fell by 4% after the results were announced.
17 Aug, 04:55 — 17 Aug, 12:30
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)3 sources25/33
Spectrum spread— 3/5 buckets covered17/33
Far L
Left1
Left (1)
Yahoo
Center1
Center (1)
investing-com
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US3
ℹAll sources from US region
Sources
Showing 3 of 3 sources
YahooMostly Factual6h ago
Jasper Therapeutics beats Q2 expectations but shares fall after results
Read full article →seeking-alphaMixed13h ago
Jasper Therapeutics GAAP EPS of -$0.10 beats by $0.22
Read full article →investing-com7h ago
Jasper Therapeutics beats earnings expectations but stock falls 4% By Investing.com - Investing.com South Africa
Jasper Therapeutics beats earnings expectations but stock falls 4% By Investing.com Investing.com South Africa
Read full article →Coverage Timeline
First report: seeking-alpha · 17 Aug, 04:55|Full coverage: 3 · 8h|Window: 8h
Left-leaningCenterRight-leaning
